GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Zenotech Laboratories Ltd

Zenotech Laboratories Q1 FY27 Net Loss Rs. 45.55 lakhs; AGM on September 25, 2026

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 28 Jul 2026, 02:47 PM IST  ·  BSE ID: 81faf7e1-a83f-4637-b113-72a9dc39e688
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a net loss of Rs. 45.55 lakhs for the latest quarter and will hold its annual shareholder meeting in September.
🤖 AI Summary
  • Zenotech Laboratories reported an Unaudited Standalone Net Loss of Rs. 45.55 lakhs for the quarter ended June 30, 2026.
  • Total Income for Q1 FY27 was Rs. 1,104.79 lakhs, compared to Rs. 1,023.16 lakhs in Q1 FY26.
  • The 37th Annual General Meeting (AGM) is scheduled for Friday, September 25, 2026, at 10:30 A.M. IST.
  • Shareholders are advised to update their details with depositories or the Company’s RTA to receive AGM communications.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net Profit/(Loss) for the period
(45.55) Rs in lakhs
Not comparable — limited prior period data.
Revenue from operations
959.64 Rs in lakhs
+11.08%
Total Income
1,104.79 Rs in lakhs
+7.98%
Earnings/(Loss) per share (Basic)
(0.07)
Not comparable — limited prior period data.
🏢 How This Affects the Company
💰
Financial Impact
The company's Net Loss of Rs. 45.55 lakhs for Q1 FY27 follows a Net Loss of Rs. 107.21 lakhs for the full FY26. Total income increased to Rs. 1,104.79 lakhs from Rs. 1,023.16 lakhs year-on-year for the quarter.
⚠️
Risk Impact
The sustained net loss continues the trend of unprofitability seen in FY26, indicating ongoing financial challenges for the company. The company notes that material matters relating to irregularities prior to November 12, 2011, were abated/settled and are not material financially.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are requested to update their information with depositories or the Company’s RTA to ensure receipt of the AGM notice and Annual Report.
👤
Who Is Affected
All shareholders are affected by the company's financial results and the upcoming 37th Annual General Meeting, where key decisions may be discussed.
🔍
Management Signal
Management is progressing with regulatory compliance by approving Q1 FY27 results and scheduling the 37th AGM, indicating adherence to corporate governance requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
37th Annual General Meeting on September 25, 2026 — review outcome and any resolutions.
Release of Annual Report — examine detailed financial performance and strategic outlook.
Q2 FY27 financial results — assess if profitability trend reverses from current loss.
MEDIUM RISK Sustained net losses and declining profitability signal ongoing financial performance challenges.
💡 Investor Takeaway
Zenotech Laboratories reported a Net Loss of Rs. 45.55 lakhs for Q1 FY27, a decrease from a Net Profit of Rs. 98.96 lakhs in Q1 FY26. Total Income for the quarter increased to Rs. 1,104.79 lakhs from Rs. 1,023.16 lakhs year-on-year.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from operations increased to Rs. 959.64 lakhs in Q1 FY27 from Rs. 863.91 lakhs in Q1 FY26.
  • Other operating income showed stability at Rs. 101.58 lakhs in Q1 FY27, compared to Rs. 100.41 lakhs in Q1 FY26.

⚠️ Concerns

  • The company recorded a Net Loss of Rs. 45.55 lakhs for the quarter ended June 30, 2026, compared to a profit of Rs. 98.96 lakhs in the prior year period.
  • Earnings per share (basic and diluted) were (0.07) for Q1 FY27, a decrease from 0.16 in Q1 FY26.
📅 Company Track Record
Zenotech Laboratories reported a Net Loss of Rs. 45.55 lakhs in Q1 FY27, following a net loss of Rs. 107.21 lakhs for the full FY26. This was a reversal from a profit of Rs. 561.29 lakhs in the prior year, largely driven by a Rs. 477.18 lakhs deferred tax charge in FY26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Zenotech Laboratories' net loss for the quarter ended June 30, 2026?
Zenotech Laboratories reported an Unaudited Standalone Net Loss of Rs. 45.55 lakhs for the quarter ended June 30, 2026.
When is Zenotech Laboratories' 37th Annual General Meeting scheduled?
The 37th Annual General Meeting of Zenotech Laboratories is scheduled for Friday, September 25, 2026, at 10:30 A.M. IST through Videoconferencing.
What was Zenotech Laboratories' total income for Q1 FY27?
Zenotech Laboratories' Total Income for the quarter ended June 30, 2026, was Rs. 1,104.79 lakhs.
What were the earnings per share for Zenotech Laboratories in Q1 FY27?
The Basic and Diluted Earnings per share for Zenotech Laboratories for the quarter ended June 30, 2026, were (0.07).

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.